Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 341

  • Sort by Relevance to quickly find articles that most closely match your query.

The treatment of hyperinsulinemic hypoglycaemia in adults: an update.

Davi MV, Pia A, Guarnotta V, Pizza G, Colao A, Faggiano A; NIKE Group.

J Endocrinol Invest. 2016 Sep 13. [Epub ahead of print] Review.


Letter: investigating the intestinal mucosa-associated microbiota - relevance and potential pitfalls.

Pagnini C, Delle Fave G.

Aliment Pharmacol Ther. 2016 Sep;44(6):647-8. doi: 10.1111/apt.13686. No abstract available.


Functional single nucleotide polymorphisms within the cyclin-dependent kinase inhibitor 2A/2B region affect pancreatic cancer risk.

Campa D, Pastore M, Gentiluomo M, Talar-Wojnarowska R, Kupcinskas J, Malecka-Panas E, Neoptolemos JP, Niesen W, Vodicka P, Delle Fave G, Bas Bueno-de-Mesquita H, Gazouli M, Pacetti P, Di Leo M, Ito H, Klüter H, Soucek P, Corbo V, Yamao K, Hosono S, Kaaks R, Vashist Y, Gioffreda D, Strobel O, Shimizu Y, Dijk F, Andriulli A, Ivanauskas A, Bugert P, Tavano F, Vodickova L, Federico Zambon C, Lovecek M, Landi S, Key TJ, Boggi U, Pezzilli R, Jamroziak K, Mohelnikova-Duchonova B, Mambrini A, Bambi F, Busch O, Pazienza V, Valente R, Theodoropoulos GE, Hackert T, Capurso G, Martina Cavestro G, Pasquali C, Basso D, Sperti C, Matsuo K, Büchler M, Khaw KT, Izbicki J, Costello E, Katzke V, Michalski C, Stepien A, Rizzato C, Canzian F.

Oncotarget. 2016 Jul 29. doi: 10.18632/oncotarget.10935. [Epub ahead of print]


[Epidemiology, clinical features and treatment of chronic pancreatitis: current knowledge and future perspectives].

Capurso G, Archibugi L, Stigliano S, Delle Fave G.

Recenti Prog Med. 2016 Jun;107(6):328-36. doi: 10.1701/2296.24696. Italian.


Digestive neuroendocrine neoplasms: A 2016 overview.

Merola E, Rinzivillo M, Cicchese N, Capurso G, Panzuto F, Delle Fave G.

Dig Liver Dis. 2016 Aug;48(8):829-35. doi: 10.1016/j.dld.2016.04.008. Epub 2016 Apr 30. Review.


A Case of Pancreatic Small Cell Neuroendocrine Carcinoma Associated With SIADH.

Pescatori LC, Festa S, Panzuto F, Pilozzi E, Prosperi D, Rinzivillo M, Pizzichini P, Iaquinto G, Iannicelli E, Mené P, Delle Fave G, Capurso G.

Pancreas. 2016 May-Jun;45(5):e20-2. doi: 10.1097/MPA.0000000000000558. No abstract available.


Endoscopic scores for inflammatory bowel disease in the era of 'mucosal healing': Old problem, new perspectives.

Pagnini C, Menasci F, Desideri F, Corleto VD, Delle Fave G, Di Giulio E.

Dig Liver Dis. 2016 Jul;48(7):703-8. doi: 10.1016/j.dld.2016.03.006. Epub 2016 Mar 14. Review.


Statin Use and Survival in Resectable Pancreatic Cancer: Confounders and Mechanisms.

Archibugi L, Capurso G, Delle Fave G.

Am J Gastroenterol. 2016 Mar;111(3):436. doi: 10.1038/ajg.2015.412. No abstract available.


Risk of pancreatic malignancy and mortality in branch-duct IPMNs undergoing surveillance: A systematic review and meta-analysis.

Crippa S, Capurso G, Cammà C, Delle Fave G, Castillo CF, Falconi M.

Dig Liver Dis. 2016 May;48(5):473-9. doi: 10.1016/j.dld.2016.02.003. Epub 2016 Feb 18. Review.


Patient-reported outcomes with lanreotide Autogel/Depot for carcinoid syndrome: An international observational study.

Ruszniewski P, Valle JW, Lombard-Bohas C, Cuthbertson DJ, Perros P, Holubec L, Delle Fave G, Smith D, Niccoli P, Maisonobe P, Atlan P, Caplin ME; SYMNET study group.

Dig Liver Dis. 2016 May;48(5):552-8. doi: 10.1016/j.dld.2015.12.013. Epub 2016 Jan 15.


ENETS Consensus Guidelines Update for Gastroduodenal Neuroendocrine Neoplasms.

Delle Fave G, O'Toole D, Sundin A, Taal B, Ferolla P, Ramage JK, Ferone D, Ito T, Weber W, Zheng-Pei Z, De Herder WW, Pascher A, Ruszniewski P; Vienna Consensus Conference participants.

Neuroendocrinology. 2016;103(2):119-24. doi: 10.1159/000443168. Epub 2016 Jan 19. No abstract available.


ENETS Consensus Guidelines Update for Neuroendocrine Neoplasms of the Jejunum and Ileum.

Niederle B, Pape UF, Costa F, Gross D, Kelestimur F, Knigge U, Öberg K, Pavel M, Perren A, Toumpanakis C, O'Connor J, O'Toole D, Krenning E, Reed N, Kianmanesh R; Vienna Consensus Conference participants.

Neuroendocrinology. 2016;103(2):125-38. doi: 10.1159/000443170. Epub 2016 Jan 12. No abstract available.


ENETS Consensus Guidelines Update for the Management of Patients with Functional Pancreatic Neuroendocrine Tumors and Non-Functional Pancreatic Neuroendocrine Tumors.

Falconi M, Eriksson B, Kaltsas G, Bartsch DK, Capdevila J, Caplin M, Kos-Kudla B, Kwekkeboom D, Rindi G, Klöppel G, Reed N, Kianmanesh R, Jensen RT; Vienna Consensus Conference participants.

Neuroendocrinology. 2016;103(2):153-71. doi: 10.1159/000443171. Epub 2016 Jan 5. No abstract available.


ENETS Consensus Guidelines for High-Grade Gastroenteropancreatic Neuroendocrine Tumors and Neuroendocrine Carcinomas.

Garcia-Carbonero R, Sorbye H, Baudin E, Raymond E, Wiedenmann B, Niederle B, Sedlackova E, Toumpanakis C, Anlauf M, Cwikla JB, Caplin M, O'Toole D, Perren A; Vienna Consensus Conference participants.

Neuroendocrinology. 2016;103(2):186-94. doi: 10.1159/000443172. Epub 2016 Jan 5. No abstract available.


ENETS Consensus Guidelines Update for the Management of Distant Metastatic Disease of Intestinal, Pancreatic, Bronchial Neuroendocrine Neoplasms (NEN) and NEN of Unknown Primary Site.

Pavel M, O'Toole D, Costa F, Capdevila J, Gross D, Kianmanesh R, Krenning E, Knigge U, Salazar R, Pape UF, Öberg K; Vienna Consensus Conference participants.

Neuroendocrinology. 2016;103(2):172-85. doi: 10.1159/000443167. Epub 2016 Jan 5. No abstract available.


ENETS Consensus Guidelines Update for Colorectal Neuroendocrine Neoplasms.

Ramage JK, De Herder WW, Delle Fave G, Ferolla P, Ferone D, Ito T, Ruszniewski P, Sundin A, Weber W, Zheng-Pei Z, Taal B, Pascher A; Vienna Consensus Conference participants.

Neuroendocrinology. 2016;103(2):139-43. doi: 10.1159/000443166. Epub 2016 Jan 5. No abstract available.


ENETS Consensus Guidelines for Neuroendocrine Neoplasms of the Appendix (Excluding Goblet Cell Carcinomas).

Pape UF, Niederle B, Costa F, Gross D, Kelestimur F, Kianmanesh R, Knigge U, Öberg K, Pavel M, Perren A, Toumpanakis C, O'Connor J, Krenning E, Reed N, O'Toole D; Vienna Consensus Conference participants.

Neuroendocrinology. 2016;103(2):144-52. doi: 10.1159/000443165. Epub 2016 Jan 5. No abstract available.


Everolimus for the treatment of advanced, non-functional neuroendocrine tumours of the lung or gastrointestinal tract (RADIANT-4): a randomised, placebo-controlled, phase 3 study.

Yao JC, Fazio N, Singh S, Buzzoni R, Carnaghi C, Wolin E, Tomasek J, Raderer M, Lahner H, Voi M, Pacaud LB, Rouyrre N, Sachs C, Valle JW, Delle Fave G, Van Cutsem E, Tesselaar M, Shimada Y, Oh DY, Strosberg J, Kulke MH, Pavel ME; RAD001 in Advanced Neuroendocrine Tumours, Fourth Trial (RADIANT-4) Study Group.

Lancet. 2016 Mar 5;387(10022):968-77. doi: 10.1016/S0140-6736(15)00817-X. Epub 2015 Dec 17.


Risk for Colorectal Adenomas Among Patients with Pancreatic Intraductal Papillary Mucinous Neoplasms: a Prospective Case-Control Study.

Panic N, Capurso G, Attili F, Vitale G, Stigliano S, Delle Fave G, Leoncini E, Bulajic M, Di Giulio E, Costamagna G, Boccia S, Larghi A.

J Gastrointestin Liver Dis. 2015 Dec;24(4):445-50. doi: 10.15403/jgld.2014.1121.244.rsk.


Predictive factors of response to mTOR inhibitors in neuroendocrine tumours.

Zatelli MC, Fanciulli G, Malandrino P, Ramundo V, Faggiano A, Colao A; NIKE Group.

Endocr Relat Cancer. 2016 Mar;23(3):R173-83. doi: 10.1530/ERC-15-0413. Epub 2015 Dec 14. Review.

Items per page

Supplemental Content

Loading ...
Write to the Help Desk